Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Older adults often have skin problems due to aging, and treating these conditions requires attention to both physical and mental health.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

VEGF-A is crucial for normal skin function and may be linked to psoriasis.

Carbamazepine caused hair loss in a man, which stopped after he stopped taking the drug.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Turpentine ointment is effective and safe for treating folliculitis.

Tinea faciei should be considered in neonatal vesicular lesions and confirmed with KOH examination and culture.

Abnormal ECM and immune cell interactions can cause skin diseases.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

New medications could improve treatment for severe alopecia areata in Australia.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Applying DMG-Na to the skin increases blood flow and may help with skin conditions.

Fullerene C60 shows promise as a new treatment for various skin conditions.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Stem cell therapy shows promise for treating skin disorders.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Air pollution harms skin health and can worsen skin diseases.